Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy

Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy

US Patent 11478548 · Granted Oct 25, 2022

Estimated economic value: $112,265,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for targeting activin signaling to treat cancer2025
Methods of treating or preventing cancer with an agent that depletes tregs and a2025
Combination of immunotherapy with local chemotherapy for the treatment of malign2023
Checkpoint blockade and microsatellite instability2023
Bacterial biofilms and cancer2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023
Checkpoint blockade and microsatellite instability2023
Inhibition of YAP for breaking tumor immune tolerance2022